The Lancet Oncology

Transforming oncology care in Latin America: artificial intelligence-driven solutions to bridge workforce gaps

Pub Date : 2025-02-03 DOI: 10.1016/s1470-2045(24)00681-8 Fabio Y Moraes, Michael Yan, Ada Muellner, Hedvig Hricak

Common Sense Oncology principles for the design, analysis, and reporting of phase 3 randomised clinical trials

Pub Date : 2025-02-03 DOI: 10.1016/s1470-2045(24)00451-0 Bishal Gyawali, Elizabeth A Eisenhauer, Winette van der Graaf, Christopher M Booth, Nathan I Cherny, Aaron M Goodman, Rachel Koven, Madeline L Pe, Bernard L Marini, Ghulam Rehman Mohyuddin, Gregory R Pond, Manju Sengar, Enrique Soto-Perez-de-Celis, Dario Trapani, Michelle Tregear, Brooke E Wilson, Ian F Tannock

Rucaparib versus chemotherapy for treatment of relapsed ovarian cancer with deleterious BRCA1 or BRCA2 mutation (ARIEL4): final results of an international, open-label, randomised, phase 3 trial

Pub Date : 2025-02-03 DOI: 10.1016/s1470-2045(24)00674-0 Amit M Oza, Alla Lisyanskaya, Alexander Fedenko, Andreia Cristina de Melo, Yaroslav Shparyk, Irina Rakhmatullina, Igor Bondarenko, Nicoletta Colombo, Valentyn Svintsitskiy, Luciano Biela, Marina Nechaeva, Domenica Lorusso, Giovanni Scambia, David Cibula, Róbert Póka, Ana Oaknin, Tamar Safra, Beata Mackowiak-Matejczyk, Ling Ma, Daleen Thomas, Rebecca Kristeleit